TABLE 3

Baseline characteristics of all patients included in the second phase of the study

Patients30
Age years68.9±9.6
Male18 (60.0)
Presentation
 Outpatient23 (76.7)
 Emergency admission7 (23.3)
ECOG Performance Status
 06 (20.0)
 115 (50.0)
 28 (26.7)
 31 (3.3)
Nodal stage#
 N220 (66.7)
 N310 (33.3)
Metastatic disease12 (40.0)
Cancer subtype
 Small cell lung cancer6 (20.0)
 Adenocarcinoma16 (53.3)
 Squamous cell carcinoma8 (26.7)
 NSCLC NOS0

Data are presented as n, mean±sd or n (%). ECOG: Eastern Cooperative Oncology Group; NSCLC NOS: nonsmall cell lung cancer not otherwise specified. #: nodal stage defined by computed tomography.